1. The Use of Oral, Topical and Intravenous Detoxification Strategies in the Management of Cancer and Other Diseases Victor A Marcial-Vega,MD www.marcialvegamd.com marcialvegamd@aol.com April 2013

2. Patient Population n 210 Patients in Puerto Rico n Age Range 10-88 years old n 98% Treated between 2/08-9/10 n Treated in our clinic since 7-1-10 n Before 7-1-10 treated at home n 27 excluded from results analysis

3. Baseline Studies n CBC n CMP-20 n Lipid Profile n Salivary pH (Alkaline versus Acid) n High Resolution Blood Imaging n CT Scans, PET scans, etc. n Heavy Metals

4. Heavy Metals n 21 patients tested n 100% presence of metals n Lead, mercury, aluminum n Cadmium, gadolinium, platinum, tin, nickel n Uranium, cesium

5. Goals of Treatment n To promote well being in our patients n Remove toxins n Regenerate tissue

6. TREATMENT n Goji n Chlorella n Lactobacillus n Vitamin C n Meditation CD n Essential Oils

7. Meditation CD n 50 patients n Listening daily for 2 weeks n Decrease pain medications in 50% pts n Decrease HBP meds in 20% n More calm and focused n More aware of what is causing their discomfort

8. Essential Oils n Pain, Peppermint, Circulation n Birch, Marjoram, Sages, Lavender n 150 patients n 90% reduction or dissapearance of pain n Effects noted in 5 minutes n No side effects

9. Essential Oils for Relaxation n Stress Blend n Meditation Blend n Anxiety n Fem Balance n Geranium Rose, Y lang, Juniper Berry, Orange Peel, Patchouli, Vetiver, Chamomille blue,

10. IV Therapies n Vitamin C above 5 grams 83% n EDTA 50% n Na 2 CO 3 35% n H 2 0 2 6% n Glutathione17%

11. Vitamin C Treatments n 1036 n Average Number of Treatments n Per patient 12

12. IV Vitamin C Indications n Feeling Better n More Energy n Cancer (on chemo or radiation) n Before Surgery n As a treatment for Cancer or any other disease n 3x-5x week

13. EDTA Indications n Any Disease n Cardiovascular Plaque Formation n Once a week

14. Bicarbonate Indications n Salivary pH less than 7.0 n Now, we see that aggressive IV Vitamin C can alkalinize most patients

15. Glutathione Indications n Parkinson’s disease, patients on any chemotherapy (risk of neuropathy) n Nerve or brain damage

16. Hydrogen Peroxide n Presence of Infection n Or risk of an infection after a procedure

17. EDTA Treatments n 665 n 6 per patient

18. Na2Co3 Treatments n 365 n Average Treatments/pt = 5

19. Glutathione n Total Number 94 n Average Per patient 3

20. H202 n Total 38 n Average/pt 3

21. RESULTS FLU AND RESPIRATORY n 22 patients with influenza, bronchiectasia, asthma or chronic bronchitis n One treatment of either Vitamin C, Bicarbonate or hydrogen peroxide clears 50% of symptoms during the infusion n One pt increased flow from 44 to 88%

22. FLU AND RESPIRATORY n Overall response was 21/22 during the IV (95%) n 17 patients rapidly improved within 6 hours after the IV n Vit C 20-50 g n Hydrogen Peroxide 3cc n Sodium Bicarbonate 150-200 cc

23. ARTHRITIS n 9 patients n Marked improvement or disappearance of pain in 8/9 patients n One patient got worse from treatment and she was on methotrexate and prednisone

24. CHOLESTEROL n 19/21 had a marked improvement n Decrease in Cholesterol (84%) n Decrease or elimination of meds (81%) n Decreased obstruction of vessels n Lowering of Blood Pressure (85%)

25. DIABETES n 12 patients n Improved sugar levels in all patients n Improved quality of life n Stopped medication-2

26. GENERAL n 46 patients n Sleeping better and more energy

27. Cancer Palliation n 6 patients n Improvement of Symptoms in 3 (50%) n Enhanced quality of life and n death process

28. Treatment of Side Effects from chemotherapy and Radiation n 13 patients n 100% Resolution of Symptoms n Nausea, vomiting, joint pains, diarrhea, insomnia, low energy, bronchtis, allergies, asthma, leg swelling

29. RESULTS AS SOLE TREATMENT n Cancer Patients n 60 n Treatment Alone n Most were Stage 4 n 43/60= 72% Response Rate

30. RESPONSE n Reduction of Tumor 27/60=45% n Increased Energy and Wellbeing n Increased Quality of Life n Improvement of Symptoms n 4 had a complete response 7% n 2 additional CR unbiopsed (6/60=10%) n Heavily Treated Patients (chemo, rt)

31. Case Histories n Metastatic Ovarian Carcinoma n 51 years old n CA-125 down from 26 to 12 then up to 65, Alkaline Phosphatase down, decreased urine protein down 10 x 44.5g, 3 x 150, 3 x.7, 3 x 1.8 Glut. Patient Stable for 1 year

32. Hypernephroma n 71 years old n Decreased Kidney Nephroma n Tumor from 12 x 13 to 5 x 7 cm. Improved KS n 31 x 32g 6 x 158 cc 23 x 3g DIED from chemotherapy complications

33. Metastatic Breast Cancer n 58 years old n 2 x.7 10 x 40g 4 x 156 cc n Drop in Alkaline Phosphatase n Drop in Liver Function Studies n Complete Resolution of Severe Pain

34. Prostate Cancer n Progression of PSA elevation n 8 x 2.44, 17 x 61 g n Decrease of PSA after stress reduction n modalities

35. Multiple Myeloma n 20(2.1 grams), 20(64 grams) Decline in IgG, mspike, gamma globulin, urine m-spike) Decline in IgG, mspike, gamma globulin, urine m-spike) n

36. Breast Cancer Nodal Recurrence n Reduction from 4x4 to 3 x 3.5 2(20), 23(159)

37. Metastatic Carcinoid n 19(40), 1-150 n Disappearance of cough and 2 lung infiltrates n 5 Hydroxy Indol Acetic Acid n 12.1 to 7.0 to 3.4 4-8-10, Down to 2.4 9-8-10

38. Recurrent Prostate Cancer n 39(2.6g), 46(45g), 2(150cc), 3(1.9g) n PSA from 26 to.38 n One year no evidence of disease

39. Metastatic renal cell carcinoma n R DJD node gone n 4 x 4 fixed n Died of uncontrolled disease n 4(15), 2(125) n Stopped Treatment

40. Metastatic Pancreatic CA n 7(31), 2(200) n Peaceful Death n Walking until the day he died

41. Recurrent AM Leukemia n Hb up from 7.2 to 8.6 in 3 weeks, 12(48) n More energy and stamina n Another patient had increase in Hb from 9 to 12.5

42. Stage 4 Ulcerated Breast CA n Tumor reduced in size from 14.5x10(16 circumference) to 7x11(12 circumference) n 60% by volume n 14(62), 4(200)

43. Adnexal Mass(Fallopian Tube) n Severe pain, bleeding, 8.5 x 4 cm by Sonogram and CT n Reduced by ½ in one week n Bleeding stopped no pain or fevers. 3(35), 2(200),1(3) n Operated 9-16-10

44. Concomitant RT and/or Chemo n 27 -Reduced Side Effects n 14 complete responders = 52% n 10 More than 50% reduction of tumor n Overall Response Rate= 24/27=89% n 3 patients that responded were prohibited by oncologist to stop vitamin C. All are dead

45. Case Histories n 7 years old n Recurrent Neuroblastoma n Disappearance of Tumor Markers n Third chemotherapy program

46. Metastatic Colon Carcinoma n 67 years old n 5(.6), 20(51.5) and Cisplatin n CEA down from 133.51 to 85.66, then to 55.06 8-12, Then 8-30-10 25.22 BIGGEST DROP associated with EDTA calcium 3x week, 2(40/.9)

47. Metastatic Breast Cancer n 36 years old n 16(45) On Mab n More energy and sleeping better. Excellent response (blindness reversed) n Rash Gone

48. Metastatic Ovarian cancer n 6(29), 1(150), n CA125 2-9-9 169 n 10 9-21-09 and has stayed there until 9-10 n 2(35/.5), PET SCAN decreased to ½. Feeling great

49. Sickle Cell Anemia n 28 years old n Ferritin 2319, steadily rising for 1.5 years,went down to 1670 after 5 EDTA's (1.9) given over 2.5 months 3-9 to 5-22-09, 10(1.9), 10(150) n

50. Chronic Renal Failure n Creat 9.9, Heavy Metals, Hyperglycemia, TCC Bladder n 2(100mg) CALCIUM EDTA, 3(5 grams Vit C) Less edema, less swelling of eyelids and legs. No more pains Sleeping better n diabetic, sjogrens,renal failure, improved skin and decreased creatinine from 3.5 to 2.78, 9(.180), 3(7.7)

51. COMPLICATIONS n 2198 infusions n 38/2198=2% n Serious =.2% n Of patients, 2% serious n Hipoglycemia 9 patients n Clot from axilla to fingers n Lower in a clinic setting

52. COMPLICATIONS n Death associated to Toprol induced bradychardia. n Minor Side Effects-General malaise, fatigue, worsening of pain, thirst, stomach upset, dysuria, increased blood pressure, nosebleed, infiltration n Results seem much better and faster in a clinic than in a home setting

53. CONCLUSIONS n Intravenous Therapies are highly effective in the management of the flu, diabetes, vascular disease, arthritis and cancer n High dose intravenous vitamin C seems to increase the response rate of conventional chemotherapy

54. CONCLUSIONS n Intravenous Vitamin C markedly reduces side effects associated with conventional cancer treatment n Intravenous Vitamin C, EDTA and Bicarbonate can reduce tumors and markedly increase quality of life in cancer patients

55. CONCLUSIONS n EDTA/VITAMIN C intravenously is associated with a better response to treatment n All diseases are associated with heavy metals and their removal seems to lead to reversal of disease n Being told by oncologist to stop IV therapies is a negative prognostic factor